Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Phase 3
400
about 21 years
19+
1 site in NE
What this study is about
This trial is testing a treatment for rheumatoid arthritis (RA) using different medications called DMARDs. The goal is to find out what factors help predict how well people respond to these medications. Participants will receive a starting dose of one or more DMARD medications, which may be adjusted by the doctor as needed.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Abatacept
- 2.Take Adalimumab
- 3.Take Azathioprine
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
abatacept, adalimumab (Monoclonal antibody; blocks TNF-alpha to reduce inflammation), azathioprine (Antimetabolite; inhibits DNA synthesis in immune cells), baricitinib, certolizumab pegol, etanercept (TNF inhibitor (fusion protein capturing TNF-alpha)), golimumab, hydroxychloroquine (Antimalarial; increases pH in parasite)
injection, intravenous, oral (Oral Tablet), oral, infusion, oral (Delayed Release Oral Tablet)
Immune